LEADER 01345nam  2200385   450 
001 9910707868403321
005 20161213094151.0
035   $a(CKB)5470000002467873
035   $a(OCoLC)965828261
035   $a(OCoLC)995470000002467873
035   $a(EXLCZ)995470000002467873
100   $a20161213d2006      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aAllergen immunotherapy for Medicare beneficiaries /$fDepartment of Health and Human Services, Office of Inspector General
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2006.
215   $a1 online resource (iv, 28 pages) $ccolor illustrations
300   $a"February 2006."
300   $a"OEI-09-00-00531."
320   $aIncludes bibliographical references.
606   $aMedicare
606   $aAllergens$xImmunotherapy$zUnited States$xFinance
606   $aAllergens$xImmunotherapy$zUnited States$xEvaluation
615  0$aMedicare.
615  0$aAllergens$xImmunotherapy$xFinance.
615  0$aAllergens$xImmunotherapy$xEvaluation.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707868403321
996   $aAllergen immunotherapy for Medicare beneficiaries$93265898
997   $aUNINA